ישראל -
עברית -
Ministry of Health
בייאטה 5 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
ישראל -
עברית -
Ministry of Health
בייאטה 5 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
ישראל -
עברית -
Ministry of Health
בייאטה 10 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
ישראל -
עברית -
Ministry of Health
בייאטה 10 מק"ג
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
ישראל -
עברית -
Ministry of Health
ביידוריון 2 מג
astrazeneca (israel) ltd - exenatide - אבקה וממס להכנת תרחיף להזרקה - exenatide 2 mg - exenatide - exenatide - bydureon is indicated for treatment of type 2 diabetes mellitus in combination with : • metformin• sulphonylurea• metformin and sulphonylureain adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies.
ישראל -
עברית -
Ministry of Health
ביידוריון 2 מג
astrazeneca (israel) ltd - exenatide - אבקה וממס להכנת תרחיף להזרקה - exenatide 2 mg - exenatide
ישראל -
עברית -
Ministry of Health
negative pressure wound therpy system
סיסטמדיק בעמ - אחות - מערכת למניעת פצעים כרוניים ופצעי לחץ
ישראל -
עברית -
Ministry of Health
kalypto npd-negative pressure wound care system
איב ואיילת אחזקות בע"מ - אחות - מכשיר ואקום לטיפול בפצעים -לטיפול בפצעים קשיי רפוי
ישראל -
עברית -
Ministry of Health
step cycle exercise-apos kit
"אפוס טכנולוגיות רפואה וספורט בע""מ" - כלל האוכלוסיה - ערכת אפוס לאימון ושיקום יציבות ושליטה עצבית-שרירית
ישראל -
עברית -
Ministry of Health
vac via negative pressure wound therapy system
כמיטק - רופא - מכשירים התומכים בסגירת פצעים